Patent ID: 8883826

Claim:
A method for treating a disorder selected from the group consisting of alcohol, nicotine, cocaine, amphetamine, benzodiazepine, analgesics, opiate or other substance dependence, and obsessive compulsive disorders, the method comprising administering to a mammalian patient in need of such treatment, an effective amount of a compound represented by the formula II-A2-a2: or a pharmaceutically acceptable salt or hydrate thereof; wherein R 1 , R 2 , R 3 and R 4 are each independently selected from the group consisting of hydrogen, halogen, optionally substituted C 1 -C 6 -alkyl, C 1 -C 6 -alkylhalo and C 0 -C 6 -alkyl-NR 5 R 6 ; R 5 and R 6 are each independently selected from the group consisting of hydrogen, optionally substituted C 1 -C 6 -alkyl, C 1 -C 6 -alkylhalo C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 6 -alkyl, heteroaryl, C 1 -C 6 -alkyl-heteroaryl, and aryl; G q groups are each independently selected from the group consisting of hydrogen, halogen, CN, an optionally substituted C 1 -C 6 -alkyl, C 1 -C 6 -alkylhalo, O—C 0 -C 6 -alkyl, O—C 0 -C 6 -alkylaryl, heteroaryl and aryl; q is an integer from 1 to 5; and any N may be an N-oxide.